▶ 調査レポート

バイオ医薬品発酵システムの世界市場(~2026年)

• 英文タイトル:Global Biopharmaceutical Fermentation Systems Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。バイオ医薬品発酵システムの世界市場(~2026年) / Global Biopharmaceutical Fermentation Systems Market Size, Status and Forecast 2020-2026 / MRC2-11QY11085資料のイメージです。• レポートコード:MRC2-11QY11085
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療機器・消耗品
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はバイオ医薬品発酵システムのグローバル市場について調査・分析したレポートです。種類別(発酵槽、バイオプロセス分析装置、プロセス監視装置、培地・培地調製、培地、バッファー・誘導剤、その他)市場規模、用途別(バイオ製薬会社、委託製造機関、委託研究機関、学術研究所、食品産業、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別バイオ医薬品発酵システムの競争状況、市場シェア
・世界のバイオ医薬品発酵システム市場:種類別市場規模 2015年-2020年(発酵槽、バイオプロセス分析装置、プロセス監視装置、培地・培地調製、培地、バッファー・誘導剤、その他)
・世界のバイオ医薬品発酵システム市場:種類別市場規模予測 2021年-2026年(発酵槽、バイオプロセス分析装置、プロセス監視装置、培地・培地調製、培地、バッファー・誘導剤、その他)
・世界のバイオ医薬品発酵システム市場:用途別市場規模 2015年-2020年(バイオ製薬会社、委託製造機関、委託研究機関、学術研究所、食品産業、その他)
・世界のバイオ医薬品発酵システム市場:用途別市場規模予測 2021年-2026年(バイオ製薬会社、委託製造機関、委託研究機関、学術研究所、食品産業、その他)
・北米のバイオ医薬品発酵システム市場分析:米国、カナダ
・ヨーロッパのバイオ医薬品発酵システム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバイオ医薬品発酵システム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバイオ医薬品発酵システム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバイオ医薬品発酵システム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GE Healthcare、Thermo Fisher Scientific、Danaher Corporation、Sartorius StedimBiotech、Merck、Eppendorf、Roche、Nova Biomedicals、Lonza、Becton、Dickinson and Company、GEA
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation.
In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. Increase in investment in research activities and introduction of new protein therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins.

Market Analysis and Insights: Global Biopharmaceutical Fermentation Systems Market
The global Biopharmaceutical Fermentation Systems market size is projected to reach US$ 9873.8 million by 2026, from US$ 9380.9 million in 2020, at a CAGR of 4.9%% during 2021-2026.

Global Biopharmaceutical Fermentation Systems Scope and Market Size
Biopharmaceutical Fermentation Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Fermentation Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GE Healthcare
Thermo Fisher Scientific
Danaher Corporation
Sartorius StedimBiotech
Merck
Eppendorf
Roche
Nova Biomedicals
Lonza
Becton
Dickinson and Company
GEA

Market segment by Type, the product can be split into
Fermenters
Bioprocess Analyzers
Process Monitoring Devices
Culture & Media Preparation
Culture Media, Buffers & Inducers
Others
Market segment by Application, split into
Biopharmaceutical Companies
Contract Manufacturing Organizations
Contract Research Organizations
Academic Research Institutes
Food Industry
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical Fermentation Systems Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Fermentation Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Fermenters
1.4.3 Bioprocess Analyzers
1.4.4 Process Monitoring Devices
1.4.5 Culture & Media Preparation
1.4.6 Culture Media, Buffers & Inducers
1.4.7 Others
1.5 Market by Application
1.5.1 Global Biopharmaceutical Fermentation Systems Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical Companies
1.5.3 Contract Manufacturing Organizations
1.5.4 Contract Research Organizations
1.5.5 Academic Research Institutes
1.5.6 Food Industry
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical Fermentation Systems Market Perspective (2015-2026)
2.2 Global Biopharmaceutical Fermentation Systems Growth Trends by Regions
2.2.1 Biopharmaceutical Fermentation Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical Fermentation Systems Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical Fermentation Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical Fermentation Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical Fermentation Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Fermentation Systems Players by Market Size
3.1.1 Global Top Biopharmaceutical Fermentation Systems Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical Fermentation Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical Fermentation Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio
3.2.1 Global Biopharmaceutical Fermentation Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Fermentation Systems Revenue in 2019
3.3 Biopharmaceutical Fermentation Systems Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical Fermentation Systems Product Solution and Service
3.5 Date of Enter into Biopharmaceutical Fermentation Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biopharmaceutical Fermentation Systems Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Biopharmaceutical Fermentation Systems Market Size (2015-2020)
6.2 Biopharmaceutical Fermentation Systems Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Biopharmaceutical Fermentation Systems Market Size (2015-2020)
7.2 Biopharmaceutical Fermentation Systems Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

8 China
8.1 China Biopharmaceutical Fermentation Systems Market Size (2015-2020)
8.2 Biopharmaceutical Fermentation Systems Key Players in China (2019-2020)
8.3 China Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
8.4 China Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Biopharmaceutical Fermentation Systems Market Size (2015-2020)
9.2 Biopharmaceutical Fermentation Systems Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Biopharmaceutical Fermentation Systems Market Size (2015-2020)
10.2 Biopharmaceutical Fermentation Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

11 India
11.1 India Biopharmaceutical Fermentation Systems Market Size (2015-2020)
11.2 Biopharmaceutical Fermentation Systems Key Players in India (2019-2020)
11.3 India Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
11.4 India Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Biopharmaceutical Fermentation Systems Market Size (2015-2020)
12.2 Biopharmaceutical Fermentation Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GE Healthcare
13.1.1 GE Healthcare Company Details
13.1.2 GE Healthcare Business Overview
13.1.3 GE Healthcare Biopharmaceutical Fermentation Systems Introduction
13.1.4 GE Healthcare Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020))
13.1.5 GE Healthcare Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Biopharmaceutical Fermentation Systems Introduction
13.2.4 Thermo Fisher Scientific Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Danaher Corporation
13.3.1 Danaher Corporation Company Details
13.3.2 Danaher Corporation Business Overview
13.3.3 Danaher Corporation Biopharmaceutical Fermentation Systems Introduction
13.3.4 Danaher Corporation Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.3.5 Danaher Corporation Recent Development
13.4 Sartorius StedimBiotech
13.4.1 Sartorius StedimBiotech Company Details
13.4.2 Sartorius StedimBiotech Business Overview
13.4.3 Sartorius StedimBiotech Biopharmaceutical Fermentation Systems Introduction
13.4.4 Sartorius StedimBiotech Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.4.5 Sartorius StedimBiotech Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Biopharmaceutical Fermentation Systems Introduction
13.5.4 Merck Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Eppendorf
13.6.1 Eppendorf Company Details
13.6.2 Eppendorf Business Overview
13.6.3 Eppendorf Biopharmaceutical Fermentation Systems Introduction
13.6.4 Eppendorf Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.6.5 Eppendorf Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Biopharmaceutical Fermentation Systems Introduction
13.7.4 Roche Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Nova Biomedicals
13.8.1 Nova Biomedicals Company Details
13.8.2 Nova Biomedicals Business Overview
13.8.3 Nova Biomedicals Biopharmaceutical Fermentation Systems Introduction
13.8.4 Nova Biomedicals Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.8.5 Nova Biomedicals Recent Development
13.9 Lonza
13.9.1 Lonza Company Details
13.9.2 Lonza Business Overview
13.9.3 Lonza Biopharmaceutical Fermentation Systems Introduction
13.9.4 Lonza Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.9.5 Lonza Recent Development
13.10 Becton
13.10.1 Becton Company Details
13.10.2 Becton Business Overview
13.10.3 Becton Biopharmaceutical Fermentation Systems Introduction
13.10.4 Becton Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
13.10.5 Becton Recent Development
13.11 Dickinson and Company
10.11.1 Dickinson and Company Company Details
10.11.2 Dickinson and Company Business Overview
10.11.3 Dickinson and Company Biopharmaceutical Fermentation Systems Introduction
10.11.4 Dickinson and Company Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
10.11.5 Dickinson and Company Recent Development
13.12 GEA
10.12.1 GEA Company Details
10.12.2 GEA Business Overview
10.12.3 GEA Biopharmaceutical Fermentation Systems Introduction
10.12.4 GEA Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020)
10.12.5 GEA Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Biopharmaceutical Fermentation Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical Fermentation Systems Revenue
Table 3. Ranking of Global Top Biopharmaceutical Fermentation Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical Fermentation Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Fermenters
Table 6. Key Players of Bioprocess Analyzers
Table 7. Key Players of Process Monitoring Devices
Table 8. Key Players of Culture & Media Preparation
Table 9. Key Players of Culture Media, Buffers & Inducers
Table 10. Key Players of Others
Table 11. Global Biopharmaceutical Fermentation Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Biopharmaceutical Fermentation Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Biopharmaceutical Fermentation Systems Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Biopharmaceutical Fermentation Systems Market Share by Regions (2015-2020)
Table 15. Global Biopharmaceutical Fermentation Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Biopharmaceutical Fermentation Systems Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Biopharmaceutical Fermentation Systems Market Growth Strategy
Table 21. Main Points Interviewed from Key Biopharmaceutical Fermentation Systems Players
Table 22. Global Biopharmaceutical Fermentation Systems Revenue by Players (2015-2020) (Million US$)
Table 23. Global Biopharmaceutical Fermentation Systems Market Share by Players (2015-2020)
Table 24. Global Top Biopharmaceutical Fermentation Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Fermentation Systems as of 2019)
Table 25. Global Biopharmaceutical Fermentation Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Biopharmaceutical Fermentation Systems Product Solution and Service
Table 28. Date of Enter into Biopharmaceutical Fermentation Systems Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 31. Global Biopharmaceutical Fermentation Systems Market Size Share by Type (2015-2020)
Table 32. Global Biopharmaceutical Fermentation Systems Revenue Market Share by Type (2021-2026)
Table 33. Global Biopharmaceutical Fermentation Systems Market Size Share by Application (2015-2020)
Table 34. Global Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 35. Global Biopharmaceutical Fermentation Systems Market Size Share by Application (2021-2026)
Table 36. North America Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 38. North America Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 39. North America Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 40. North America Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 41. North America Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 42. Europe Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 44. Europe Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 46. Europe Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 48. China Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 49. China Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 50. China Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 51. China Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 52. China Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 53. China Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 54. Japan Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 56. Japan Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 58. Japan Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 62. Southeast Asia Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 64. Southeast Asia Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 66. India Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 67. India Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 68. India Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 69. India Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 70. India Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 71. India Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Biopharmaceutical Fermentation Systems Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Biopharmaceutical Fermentation Systems Market Share (2019-2020)
Table 74. Central & South America Biopharmaceutical Fermentation Systems Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Biopharmaceutical Fermentation Systems Market Share by Type (2015-2020)
Table 76. Central & South America Biopharmaceutical Fermentation Systems Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Biopharmaceutical Fermentation Systems Market Share by Application (2015-2020)
Table 78. GE Healthcare Company Details
Table 79. GE Healthcare Business Overview
Table 80. GE Healthcare Product
Table 81. GE Healthcare Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 82. GE Healthcare Recent Development
Table 83. Thermo Fisher Scientific Company Details
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Product
Table 86. Thermo Fisher Scientific Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. Danaher Corporation Company Details
Table 89. Danaher Corporation Business Overview
Table 90. Danaher Corporation Product
Table 91. Danaher Corporation Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 92. Danaher Corporation Recent Development
Table 93. Sartorius StedimBiotech Company Details
Table 94. Sartorius StedimBiotech Business Overview
Table 95. Sartorius StedimBiotech Product
Table 96. Sartorius StedimBiotech Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 97. Sartorius StedimBiotech Recent Development
Table 98. Merck Company Details
Table 99. Merck Business Overview
Table 100. Merck Product
Table 101. Merck Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 102. Merck Recent Development
Table 103. Eppendorf Company Details
Table 104. Eppendorf Business Overview
Table 105. Eppendorf Product
Table 106. Eppendorf Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 107. Eppendorf Recent Development
Table 108. Roche Company Details
Table 109. Roche Business Overview
Table 110. Roche Product
Table 111. Roche Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 112. Roche Recent Development
Table 113. Nova Biomedicals Business Overview
Table 114. Nova Biomedicals Product
Table 115. Nova Biomedicals Company Details
Table 116. Nova Biomedicals Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 117. Nova Biomedicals Recent Development
Table 118. Lonza Company Details
Table 119. Lonza Business Overview
Table 120. Lonza Product
Table 121. Lonza Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 122. Lonza Recent Development
Table 123. Becton Company Details
Table 124. Becton Business Overview
Table 125. Becton Product
Table 126. Becton Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 127. Becton Recent Development
Table 128. Dickinson and Company Company Details
Table 129. Dickinson and Company Business Overview
Table 130. Dickinson and Company Product
Table 131. Dickinson and Company Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 132. Dickinson and Company Recent Development
Table 133. GEA Company Details
Table 134. GEA Business Overview
Table 135. GEA Product
Table 136. GEA Revenue in Biopharmaceutical Fermentation Systems Business (2015-2020) (Million US$)
Table 137. GEA Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Fermentation Systems Market Share by Type: 2020 VS 2026
Figure 2. Fermenters Features
Figure 3. Bioprocess Analyzers Features
Figure 4. Process Monitoring Devices Features
Figure 5. Culture & Media Preparation Features
Figure 6. Culture Media, Buffers & Inducers Features
Figure 7. Others Features
Figure 8. Global Biopharmaceutical Fermentation Systems Market Share by Application: 2020 VS 2026
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Contract Manufacturing Organizations Case Studies
Figure 11. Contract Research Organizations Case Studies
Figure 12. Academic Research Institutes Case Studies
Figure 13. Food Industry Case Studies
Figure 14. Others Case Studies
Figure 15. Biopharmaceutical Fermentation Systems Report Years Considered
Figure 16. Global Biopharmaceutical Fermentation Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Biopharmaceutical Fermentation Systems Market Share by Regions: 2020 VS 2026
Figure 18. Global Biopharmaceutical Fermentation Systems Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Biopharmaceutical Fermentation Systems Market Share by Players in 2019
Figure 21. Global Top Biopharmaceutical Fermentation Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Fermentation Systems as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Biopharmaceutical Fermentation Systems Revenue in 2019
Figure 23. North America Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Biopharmaceutical Fermentation Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed